Related Experiment Video
Updated: Aug 6, 2026
06:46
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
[Prognostic factor and prediction tables for clinically localized prostate cancer]
J Segarra Tomás1, F Millán Rodríguez, J Palou Redorta
1Servicio de Urología, Fundació Puigvert, Barcelona. jsegarra@fundacio-puigvert.es
Actas Urologicas Espanolas
|August 23, 2006
Summary
Prognostic factors like clinical stage, PSA, and Gleason grade predict prostate cancer spread. A new prediction table improves accuracy for selecting patients for radical prostatectomy, enhancing treatment decisions.
Area of Science:
- Urology
- Oncology
- Medical Statistics
Context:
- Prostate cancer management requires accurate prognostication.
- Radical prostatectomy is a key treatment for localized prostate cancer.
- Predicting non-localized disease is crucial for treatment selection.
Purpose:
- To identify independent prognostic factors for prostate cancer.
- To develop a predictive table for non-localized prostate cancer probability.
- To refine patient selection for radical prostatectomy.
Summary:
- Logistic regression identified clinical stage, PSA, and Gleason grade as significant prognostic factors.
- A prediction table was developed with 26.13% sensitivity and 94.65% specificity at a 50% probability cutoff.
- The study retrospectively analyzed 1293 patients undergoing radical prostatectomy.
Impact:
- The developed table can enhance prognostic accuracy for risk stratification.
- Improved prediction allows for better-tailored therapeutic indications.
- This aids in selecting patients most likely to benefit from radical prostatectomy.
